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During an infection of nonneuronal cells, bovine herpesvirus 1 (BHV-1) gene expression proceeds in a
well-defined cascade. Products of immediate-early (IE) genes are expressed first, and they activate expression
of early (E) and late (L) genes. Although the same cascade is assumed to occur during an infection of neurons
in trigeminal ganglia (TG) of cattle, no experimental data is available to support this hypothesis. Conse-
quently, we analyzed BHV-1 gene expression in bovine TG at 1, 2, 4, 7, and 15 days postinfection (dpi).
Infectious virus was detected in ocular swabs from 1 to 7 dpi but not 15 dpi. By reverse transcription (RT)-PCR,
IE (bICP4), E (thymidine kinase, ribonucleotide reductase [RR]), L (glycoprotein C, and a trans-inducing
factor), and dual-kinetic (bICP0 and bICP22) transcripts were analyzed. When cDNA synthesis was primed
with random hexamers, IE and E transcripts were detected at the same time. However, full-length and poly(A)1
(FL&P) RR or bICP22 RNAs were detected before FL&P IE RNAs. Furthermore, FL&P IE transcripts were
not detected until viral DNA increased in TG. IE transcripts were detected before E or L RNAs when rabbit
kidney cells were infected with a low multiplicity of infection and the same RT-PCR detection method was used.
These studies suggested that expression of full-length and polyadenylated IE transcripts in trigeminal ganglia
was not efficient compared to that of RR and bICP22 transcripts.
Bovine herpesvirus 1 (BHV-1) is an important pathogen of
cattle that causes respiratory, genital, or occasionally neuro-
logical disease (55). BHV-1 is classified together with varicella-
zoster virus (VZV) and pseudorabies virus in the varicellovirus
group of the Alphaherpesvirinae subfamily, Herpesviridae family
(41). However, BHV-1 has a number of biological properties
which are closely related to herpes simplex virus types 1 and 2
(HSV-1 and HSV-2) (51). BHV-1 infects cattle through the
respiratory or genital tract and replicates in the epithelia at the
site of infection (reviewed in reference 55). The virus then
invades the peripheral nervous system where it establishes a
latent infection (1, 39). Although any sensory ganglia can har-
bor latent virus, trigeminal ganglia (TG) or lumbosacral gan-
glia are considered the most important sites of latency. As
latent virus can reactivate and be transmitted to other suscep-
tible animals, infection of the peripheral nervous system is
essential for BHV-1 perpetuation. Understanding virus-host
interactions during an infection in the peripheral nervous sys-
tem will be important to develop strategies to prevent the
spread of BHV-1. No previous study has examined the expres-
sion of specific BHV-1 genes in the peripheral nervous system
of cattle.
In a similar fashion to that of other members of the Alpha-
herpesvirinae subfamily, BHV-1 genes are classified as imme-
diate early (IE), early (E), or late (L) (53). During a productive
infection of cultured cells, IE gene expression is transactivated
by a virion protein (28, 29; reviewed in reference 32), does not
require previous protein synthesis, and IE proteins regulate
viral gene expression. E gene expression is activated by IE gene
products but is independent of viral DNA replication. E pro-
teins generally play a role in viral DNA replication and are
nonstructural. Late genes are classified as g1 or g2. Low levels
of g1 gene expression occur in the absence of viral IE or E gene
expression, but maximal g1 gene expression requires viral
DNA replication and at least one IE protein. g2 gene expres-
sion requires viral DNA replication. Proteins encoded by g
genes are generally structural components of the virion, some
of which are necessary for viral entry into infected cells (51).
Although extensive viral gene expression occurs during a
lytic infection, only one transcript, the latency-associated tran-
script or latency-related transcript, is detected in ganglionic
neurons during latency (37–39). Viral gene expression may be
restricted during latency because (i) neurons lack cellular fac-
tors necessary for expression of IE genes, (ii) viral transacti-
vator proteins are absent in neurons, or (iii) neuron-specific
factors repress IE promoter activity (8, 9, 21, 25–27, 37, 38, 52).
Viral DNA replication may also be blocked in neurons, result-
ing in a nonproductive infection (22, 23). HSV-1 promoters
can be active in the nervous system in the absence of other viral
factors (16, 30), suggesting that viral gene expression in neu-
rons is also repressed after initiating transcription. As with
other alphaherpesviruses, the kinetics of viral gene expression
during an acute BHV-1 infection of TG neurons has been
assumed to be similar to the kinetics of gene expression during
a lytic infection of nonneuronal cells (38).
To identify factor(s) that restrict viral gene expression and
DNA replication in neurons, it is necessary to know the kinet-
ics of viral gene expression in neurons. We have examined the
expression of several BHV-1 genes during a primary infection
of bovine TG, the natural host of BHV-1. In bovine TG,
full-length and polyadenylated (FL&P) transcripts of RR or
bICP22 genes were detected before FL&P transcripts of bICP4
or bICP0. Since FL&P transcripts of IE genes were detected
only after the number of viral genomes in TG increased be-
tween days 2 and 4 postinfection, these studies are consistent
with the hypothesis that establishment of latency occurs be-
cause IE gene expression is inefficient in TG neurons. These
studies also suggest that polyadenylation of IE transcripts was
not efficient in TG neurons.
* Corresponding author. Phone: (402) 472-1890. Fax: (402) 472-
9690. E-mail: cj@unlinfo.unl.edu.
† Present address: Department of Microbiology, School of Medi-
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MATERIALS AND METHODS
Virus and cells. Bovine turbinate (BT) and rabbit kidney (RK) cells were
grown in Earle’s modified Eagle’s medium with 10% fetal bovine serum. The
Cooper strain of BHV-1 was obtained from the National Veterinary Services
Laboratory, Animal and Plant Health Inspection Services, Ames, Iowa. Viral
stocks were prepared by infecting BT cells at a low multiplicity of infection
(MOI), typically less than 0.01 tissue culture infectious dose 50% (TCID50) per
cell, and subsequently titrated on BT cells (35).
Time-course infections. RK cells were split 1:5 in 100-mm-diameter dishes in
modified Eagle’s medium containing 5% fetal calf serum. The following day
medium was removed, 1.5 ml of fresh medium containing the appropriate
amount of BHV-1 was added, and adsorption was performed at 4°C. The dishes
were rocked every 5 min, and after 30 min of adsorption the inoculum was
removed and 12 ml of fresh medium was added to each dish.
RNA preparation. RNA extraction from tissue culture was performed essen-
tially as described by Chomczynski and Sacchi (7). RNA concentrations were
determined spectrophotometrically (260 nm), and RNA was reprecipitated with
3 volumes of ethanol. TG from cattle were minced into small pieces, and RNA
was extracted as described previously (19). One phenol extraction was per-
formed, and the interface was saved for DNA extraction (see below).
DNA extraction. The interface from the RNA extraction was precipitated with
2 volumes of ethanol at 220°C for at least 16 h. The precipitates were resus-
pended in TEN buffer (50 mM Tris [pH 7.5], 100 mM NaCl, 10 mM EDTA)
containing 0.5% of sodium dodecyl sulfate SDS and 0.3 mg of protease K per ml
and digested overnight at 55°C. DNA was then extracted once with phenol
(Tris-equilibrated, pH . 7)-chloroform-isoamyl alcohol (25:24:1), precipitated
with 2 volumes of ethanol, and resuspended in Tris-EDTA to a final concentra-
tion of 1 mg/ml.
DNase I treatment and RT. Three micrograms of RNA was treated with 1 U
of DNase I (RNase free; Gibco BRL, Gaithersburg, Md.) for 30 min at 20.5°C in
the presence of 7 U of RNase inhibitor (RNAsin; Promega, Madison, Wis.).
After DNase I treatment, samples were incubated at 65°C for 7.5 min in the
presence of 2 mM EDTA to eliminate DNase I activity. One microgram of total
RNA (DNase I treated) plus 1 mg of primer, oligo(dT), or random hexamers in
4 ml total volume were incubated at 65°C for 7.5 min and chilled on ice (dena-
turation). Sixteen microliters of ice-cold RT mix (20 mM Tris-HCl [pH 8.3], 50
mM KCl, 2.5 mM MgCl2, 100 mg of bovine serum albumin per ml, 1 mM
dithiothreitol, 0.5 mM each deoxynucleoside triphosphate dNTP, 10 U of
RNAsin, and 100 U of RNase H-reverse transcriptase [Stratagene, La Jolla,
Calif.]) was added. The reaction mixture was incubated for 10 min at 20.5°C and
then for 90 min at 45°C. RT was terminated by incubation at 95°C for 5 min. As
a control for DNA contamination in the RNA samples, 0.5 mg of RNA (DNase
I treated) was mixed with ice-cold RT mix lacking reverse transcriptase in a final
volume of 10 ml.
PCRs. An aliquot (1.5 ml) of the RT reaction mixtures was used for each PCR.
PCRs were carried out in 50 ml of 13 commercial PCR buffer, 200 mM each
dNTP, 1 mM of each primer, and Taq polymerase. Ten percent glycerol was
added to the PCR buffer as indicated for each set of primers, and the MgCl2
concentration was as indicated for each set of primers (Table 1). Amplification
was carried out for 40 cycles (45 cycles for bovine ICP4 [bICP4]) by denaturing
at 95°C for 1 min, annealing at 65°C for 1 min, and extending at 72°C for 2 min.
Upon completion of the last cycle, the reaction mixtures were further incubated
at 72°C for 7 min to ensure complete extension of the amplified products. All
PCRs were “hot started.” The use of RNase H-RT, high temperature for reverse
transcription, 10% glycerol, and hot start in the PCRs allows amplification
through RNA regions of complex secondary structure. Quantitative PCR was
performed as previously described (13) except that amplifications were per-
formed in 50.0 ml, of which 20.0 ml was analyzed by agarose gel electrophoresis.
The radioactivity which hybridized to bovine growth hormone (BGH)-amplified
products or the BHV-1-amplified products was measured with a PhosphorIm-
ager. PCR conditions and primers are described in Table 1.
Hybridizations. DNA was electrophoresed in agarose gels and then trans-
ferred to nylon membranes by capillary blotting (19, 42). Prehybridization was
performed at 63°C for 45 min to 1 h in 13 SSPE (150 mM NaCl, 10 mM
NaH2PO4, 1 mM EDTA; pH 7), 0.23 BP (13 BP is 2% bovine serum albumin,
2% polyvinylpyrrolidone) plus 1% SDS. Hybridizations were performed for 2 to
3 h in 13 SSPE–0.23 BP–1% SDS at 62°C with at least 2 3 106 cpm of the
respective probe per ml. After hybridization, membranes were washed 3 times
for 5 min each at room temperature in 0.053 SSPE–0.05% SDS. If required,
membranes were washed again in the same buffer at hybridization temperature.
Animal experiments. Twelve BHV-1-free crossbred calves (;220 kg) were
randomly assigned to six different groups of two calves each. After sedation with
xylazine (300 mg, intramuscularly), animals in five of the groups were infected
with 108.4 TCID50 of BHV-1 per nostril and 107.8 TCID50 per eye, for a total of
108.8 TCID50 per animal. After euthanasia, the left TG of each calf was collected
in a 10-ml plastic tube and immediately frozen in an ethanol-dry ice bath.
Trigeminal ganglia were kept at 2120°C until RNA was extracted. Eye swabs
were obtained from each animal immediately after necropsy. Ocular swabs were
frozen at 270°C. After thawing, media from swabs was centrifuged at 2,000 rpm
for 10 min, and infectious virus in the supernatant was titrated by 50% endpoint
titration in monolayers of BT cells (35).
RESULTS
Selection of genes and PCR primers. To study viral gene
expression during an infection of TG, we selected PCR primers
to amplify bICP4, IETU1/E1 (IE), RR, TK (E), gC, aTIF (L),
bICP22, and bICP0 (dual-kinetics) transcripts. The four
BHV-1 IE genes are grouped into two transcription units:
IETU1 (bICP4, bICP0, and bcirc) and IETU2 (bICP22) (12,
TABLE 1. Summary of primers and PCR conditions used for this study
Transcript
PCR conditions
Hybridization probe
Primersa [MgCl2](mM)
Glyb
(%)
Taq
(U)
bICP0 1: TTC TCT GGG CTC GGG GCT GC 1.0 10 0.5 CCG CAA GGG CGG CGC GCT AGC
2: AGA GGT CGA CAA ACA CCC GCG GT
bICP22 1: GCG CTG GTC CTC CGG CTC C 1.5 10 0.5 GGC TCG CCC TCC GGT CGC G
2: CTC GCT GGC GGC GCT TGG
IETU1/E1 1: ACT GCA ACA CCT GCC GCT GCC 1.0 10 0.5 GCG GGG ACG AAG GAG CAG AAA AGC
2: TTC TGC TCC TTC GTC CCC GCT G
bICP4 1: GCG CGT GGA GGT GCT CTC CTC 1.0 2 1.0 GTC GGA CGA CGA CGA GGC CGG
2: CCC TCC CTC CCT TCC CGC G
RRc 1: GAC CGC CTG CTC GCT GCT ATC C 1.5 2 0.5 TTT CCT TTG GCC CTG ATG ACT GCC GAG
2: GCC TGT GTA GTT GGT GCT GCG GC
TK 1: GCC GCC GTA CTG GAC ATG CG 1.5 10 1.0 CGC GTC AGT TCG CGC TAG AGA TGG C
2: GCC GAG TCC CCG TAA GGC GAT
aTIF 1: CCC AAG CCC CGT TCG CAG C 1.5 10 0.5 CGG CAA ACC CAT TCG GCG GCA
2: TGC CCG CCC GCC CTT AGA A
gCd 1: GAG CAA AGC CCC GCC GAA GGA 1.5 2 0.5 GAA CCT GCC CAC GCG CTG AAA C
2: TAC GAA CAG CAG CAC GGG CGG
BGHd 1: TTT CGC CCT GCT CTG CCT GCC 1.5 2 1.0 GAC ACC TTC AAA GAG TTT GTA AGC TCC CGA
2: CCC TTC CTG CCT CCC CAC CCC
a 1 and 2, the sense of each primer. All primers are 59 to 39.
b Glycerol concentration in the reaction mix. 2, no glycerol.
c Amplifies the large and small subunit of RR.
d Primers were from Galeota et al. (13). gC primers were used to detect gC transcript and for quantitative DNA PCR. BGH primers were used as the standard for
quantitative DNA PCR.
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44, 45, 54) (Fig. 1). bICP4 is a major regulator of viral gene
expression during a productive infection and is exclusively ex-
pressed as an IE transcript (45, 54). bICP22 and bcirc are
expressed under IE and L conditions, whereas bICP0 is ex-
pressed under IE and E conditions (12, 44, 45, 54). When
transcribed at IE times, bICP4, bICP0, and bcirc all share a
common leader exon (IETU1/E1) (12, 44, 54). A set of primers
were selected, IE/1, that amplify the 39 end of IETU1/E1 (Fig.
1). Since IETU1/E1 is transcribed exclusively under IE condi-
tions, IE/1 primers detect only IE transcripts but cannot dis-
tinguish between bICP0, bICP4, or bcirc transcripts. Down-
stream from IETU1/E1, each of the three transcripts (bICP0,
bICP4, and bcirc) is spliced to a different second exon (12, 44,
54). Primers were selected that amplify the 39 end of the bICP4
transcript or the 39 end of bICP0 (Fig. 1). bICP0 primers detect
IE and E transcripts but do not amplify BHV-1 LAT (19) (Fig.
1).
Both E genes analyzed, thymidine kinase (TK) and ribonu-
cleotide reductase (RR), are important for synthesis of dNTPs.
As neurons have low dNTP levels, TK and RR are important
for replication of alphaherpesviruses in neurons (20, 34; re-
viewed in reference 40). Each of the subunits of BHV-1 RR
(R1 and R2) is translated from a different transcript (49, 50),
but the transcripts are 39 coterminal. Primers were selected to
amplify the 39 end of both transcripts. To detect the TK tran-
script, primers were selected to amplify sequences immediately
upstream of the TK stop codon (Fig. 1) (3, 31).
Both L genes studied (gC and a trans-inducing factor
[aTIF]) encode major structural proteins and are located in
the unique long region (UL) (6, 10, 28, 53). BHV-1 gC is
expressed at low levels prior to DNA synthesis and thus is
expressed as a g1 transcript during a productive infection (46).
To detect gC transcripts, we used primers previously described
(13) (Fig. 1). Although the transcript of BHV-1 aTIF has not
been precisely mapped, genomic sequences flanking its open
reading frame (ORF) contain a consensus TAATA box and
polyadenylation signals (6). Wirth et al. (53) described a RNA
expressed under g1 conditions which is consistent with the
predicted aTIF transcript in size, genomic location, and kinet-
ics of expression. Thus, we selected a set of primers that am-
plify sequences upstream of the stop codon of aTIF ORF (Fig.
1).
The sensitivity of all primers was assessed by using logarith-
mic dilutions of BHV-1 DNA. All of the primers amplified
approximately 40 copies of BHV-1 DNA (Fig. 2A and B),
indicating they have similar sensitivities.
PCR analysis of gene expression during an infection of cul-
tured cells. Although all primers detected BHV-1 DNA with
similar sensitivity, it was essential to determine whether the
primers could detect viral RNA from the same number of
infected cells and yield the expected kinetics. It is known that
BHV-1 IE transcripts are expressed prior to E or L RNAs in
productively infected cultured cells (53). Thus, experiments
were performed to determine if RT-PCR could be used to
examine the kinetics of viral gene expression. To address this
issue, RK cells (;3 3 106) were infected with BHV-1 at dif-
ferent MOIs. RNA was extracted at different times postinfec-
tion, treated with DNase I, reverse transcribed, and PCR am-
plified with the respective sets of primers. When the RT
reaction was primed with random primers [N(6)], all primers
except TK could detect viral RNA at an MOI of 0.002 TCID50/
cell (103.8 TCID50/100 mM dish; Fig. 3 through 6). When
performing the PCRs at the limit of sensitivity (0.002 TCID50/
cell), amplification occasionally did not occur, as expected.
Assuming that each infectious particle infected a different cell
and knowing that approximately 50 to 70 mg of RNA were
obtained per infected dish, each microgram of RNA should
represent approximately 100 infected cells. Three micrograms
of RNA was used for the DNase I reaction, 30% of the DNase
I reaction volume for RT and 10% of the RT reaction for the
PCR. Therefore, it was estimated that all primers were capable
of detecting viral RNAs from approximately 10 infected cells.
When RT was primed with an oligo(dT) primer [T(12–18)], the
sensitivity of all primers decreased but IE gene transcripts were
routinely detected before E or L RNAs (Fig. 3 to 6). bICP4
and bICP22 primers, but not RR, detected viral RNA at an
MOI of 0.002 TCID50/cell when cDNA synthesis was primed
with oligo(dT). When reverse transcriptase was omitted from
the RT reactions, no amplification was observed after the PCR
(data not shown). At a higher MOI (;10 TCID50/cell), all
transcripts were detected as soon as 30 min after infection and
for as long as 5 h postinfection (pi) (data not shown). In
conclusion, these studies demonstrated that all primers could
detect their respective cDNAs from an equivalent number of
FIG. 1. Location of genes and PCR primers used for study of viral gene
expression during reactivation. (A) Schematic representation (drawn to scale) of
the BHV-1 genome. Rectangles indicate internal and terminal repeats flanking
the unique short genomic region (US). Letters on top of the genome denote
HindIII fragments. HindIII fragment N9 is found in the circularized form of the
genome in infected cells. Arrows below the genome indicate locations and orien-
tations of the transcripts from the different viral genes used in this study (approx-
imately to scale). (B) Genomic location of the genes analyzed. Arrows below the
genome denote the positions of the transcripts analyzed in this study (drawn to
scale). Approximate location of the exons and introns of the respective RNAs is
also given. The two diagonal lines in HindIII fragment K indicate that the scale
is interrupted between the lines. Note that IETU1/E1 is common to bICP4 and
bICP0 (in the internal repeat) or bICP4 and bcirc (in the terminal repeat) and
bICP22 and bICP4 are diploid genes. (C) Schematic representation of the tran-
cripts analyzed in this study (drawn to scale). bICP0(IE) is the IE transcript from
which bICP0 is translated. bICP0(E) is the early transcript from which bICP0 is
translated and is colinear with the second exon of bICP0(IE). bICP22(IE) is the
IE transcript from which bICP22 is translated. bICP22(L) is the late transcript
from which bICP22 is translated, and it is identical to bICP22(IE). For clarity,
most transcripts are presented in the same orientation. The exception is BHV-1
latency-associated transcript RNA, which is drawn in the opposite orientation to
show its overlap with bICP0(IE) and bICP0(IE) transcripts. Arrows represent
the transcripts. Open boxes on top of the transcripts represent ORFs. Dark black
rectangles at the bottom of each transcript represent the regions of the respective
RNAs amplified in the PCRs. (Top) IE transcripts. The cross-hatched rectangles
at the left end of bICP4, bICP0(IE), bICP0(IE), and bcirc indicate the untrans-
lated exon that is shared by the three IE transcripts (IETU1/E1). Note that IE/1
primers amplify the transcripts of bICP4, bICP0, and bcirc. bICP0 and bICP4 are
also amplified by a second set of primers used in this study. (Center) E tran-
scripts. The dashed line at the end of the TK transcript indicates the long 39 end
of this transcript (3). Note that RR primers amplify the transcripts from both RR
subunits. (Bottom) L transcripts. Note that bICP22 (L) is identical to bICP22
(IE) and that no primers amplify bcirc (L).
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infected cells and that RT-PCR can yield the expected cascade
of viral gene expression in productively infected cells.
Experimental infection of calves. Ten calves were infected
with BHV-1, and 9 were euthanized at different times postin-
fection. One infected calf died as a consequence of a secondary
bacterial infection. Two uninfected calves were used as con-
trols. Infectious virus was detected in swabs taken from the
eyes of all infected calves from 1 to 7 days pi. All infected
animals showed clinical symptoms, including dyspnea, kerati-
tis, conjunctivitis, and apathy. The severity of symptoms
peaked between 4 and 6 days pi. The animal necropsied on day
15 pi had completely recovered from clinical disease by the
time of necropsy, and infectious virus was not detected in eye
swabs. All calves were BHV-1 seronegative at the beginning of
the experiment, and only the animal euthanized at day 15 pi
seroconverted, confirming the calves were not previously ex-
posed to BHV-1. In summary, the clinical data are consistent
with those of previous studies which examined the experimen-
tal infection of calves with BHV-1 (11).
PCR analysis of gene expression during an in vivo acute
infection of TG. At the time of necropsy, TG were collected
and immediately frozen. RNA was then extracted from the
TG, DNase I treated, reverse transcribed, and PCR amplified
with the different primers. None of the primers amplified
cDNAs from noninfected calves or from infected animals nec-
ropsied at 1 day pi (Fig. 7 to 10, lanes MI and 1, respectively).
When expression of viral transcripts was analyzed in the N(6)-
primed cDNAs, most primers detected viral RNA from 2 to 7
days pi. Surprisingly, bICP4 was detected at 2 days pi in only 2
of 3 PCRs from one calf (no. 73), 1 of 3 PCRs from the other
calf (no. 100), 3 of 4 PCRs at 4 days pi from one calf (no. 89),
and 2 of 4 PCRs from the other calf (no. 90), suggesting the
levels of bICP4 were low (Fig. 6). gC was detected at 2 and 4
days pi in 1 of 2 PCRs from one calf (no. 73 and 89, respec-
tively; Fig. 10).
When cDNA synthesis was primed with T(12–18), RR and
bICP22 were the only viral transcripts detected at 2 days pi
(Fig. 8 and 9). RR and bICP22 were also consistently detected
at 4 or 7 days pi but not at 15 days pi. Transcripts from bICP4
and IETU1/E1 (IE) were not detected until 4 days pi (Fig. 7).
Furthermore, transcripts of bICP0 (IE and E), TK (E), aTIF
(L), and gC (L) were not detected until 7 days pi (Fig. 8 to 10).
Only IE/1 and bICP22 primers amplified T(12–18)-primed
cDNA from the calve euthanized at 15 days pi (Fig. 7 to 10).
RR or TK transcripts were not detected at 15 days pi (Fig. 9).
If reverse transcriptase was omitted from the RT reactions,
amplified products were not observed after the PCR (data not
shown). In summary, FL&P IE transcripts in TG were first
detected at the peak of the acute infection (Fig. 7). Surpris-
ingly, FL&P RR or bICP22 transcripts were consistently de-
tected before bICP4 or bICP0 transcripts (Fig. 7 to 9).
PCR quantitation of viral DNA in TG during an in vivo
acute infection. To examine the levels of viral DNA in TG of
infected cattle, quantitative PCR was performed as described
previously (13). This assay relies on coamplification of a viral
gene, gC, and a bovine gene, BGH. Viral DNA was not de-
tected at day 1 pi by the quantitative technique (Fig. 11) or by
a standard DNA PCR (data not shown). At 2 days pi, approx-
imately 1024.05 copies of viral DNA/cell equivalent were
present (Fig. 11B). The gC/BGH signal ratio (which is propor-
tional to the logarithm of the relative amount of viral DNA)
increased 1.5-fold between days 2 to 4 and 2-fold between days
2 to 7 (Fig. 11). At 7 days pi, the levels of viral DNA in TG was
approximately 1022.51 copies of viral DNA/cell equivalent. At
15 days pi, the levels of viral DNA in TG were similar to those
at 4 days pi. A similar result was obtained with HSV-1 during
a primary infection of mouse TG (15). In summary, these
studies indicated that the levels of viral DNA increased in TG
during an acute infection.
DISCUSSION
In this report, we examined the temporal pattern of BHV-1
transcription in bovine TG. Detection of IE transcripts
(FL&P) was after detection of RR and bICP22 transcripts
(FL&P) and followed an increase of viral DNA in TG. It was
not possible to determine whether the increase of viral DNA in
TG was due to replication in neurons versus new viral particles
entering the TG. One of the most abundant viral RNAs in
lytically infected cells, gC (10, 46, 53), was difficult to detect in
TG. Based on immunocytochemistry, it appears that most viral
gene expression in TG occurred in neurons (data not shown)
FIG. 2. Analysis of sensitivity of primers directed against BHV-1 genes. Log-
arithmic dilutions of purified BHV-1 DNA (13) were PCR amplified in inde-
pendent experiments, using the primers described in Table 1. Amplified products
were electrophoresed in agarose gels, blotted to a nylon membrane, and hybrid-
ized with the respective probes. For each set of primers, the last three positive
dilutions and the first negative dilution of BHV-1 DNA are presented. Numbers
on the top and bottom of each blot indicate the estimated number of viral
genome copies used as a template for each reaction. (A) Amplification of bICP4
and IE/1 (IE genes) or bICP0 and bICP22 (dual-kinetic genes). (B) Amplifica-
tion of RR and TK (E genes) or gC and aTIF (L genes).
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which is consistent with results of a previous study (18). These
results suggested that the cascade of viral gene expression was
altered in TG, and consequently we hypothesized this may
favor the establishment of latency.
Genes that should be important for a productive infection of
neurons were chosen for amplification. The sequences of some
BHV-1 E genes (such as DNA polymerase) were not available
to the public at the time these experiments were performed.
FIG. 3. Detection of IE transcripts during an in vitro lytic infection. cDNAs from RK cells infected with 0.002 or 0.02 TCID50 of BHV-1 per 100-mm-diameter dish
(0.002 and 0.02, respectively), and positive and negative controls were PCR amplified, blotted to a nylon membrane, and hybridized with the respective probes. RNA
was extracted at 90, 120, 150, or 180 min after infection as indicated. RNA was treated with DNase I, reverse transcribed with the indicated primer, and PCR amplified
with either bICP4 (left panels) or IE/1 (right panels) primer. As a positive control, we used BHV-1 DNA (1). As negative controls we used RNA from mock-infected
cells (MI) and also amplifications in reaction tubes to which no template was added (not shown). The 1 lane in N(6) and T(12–18) of the bICP4 panels is the same positive
control, as bICP4-amplified products from both bICP4 PCRs, N(6) and T(12–18)-primed cDNAs were run in the same gel. PCRs from both N(6) and T(12–18) cDNAs
were run at the same time with the same PCR mix. (Top panels) Amplification from bICP4 or IETU1/E1 RNA in random-primed cDNA [N(6)]. (Bottom panels)
Amplification from bICP4 or IETU1/E1 RNA in oligo(dT)-primed cDNA [T(12–18)].
FIG. 4. Detection of dual-kinetics transcripts during an in vitro lytic infection. Infections, RNA extraction and processing, and controls were the same as described
in the legend to Fig. 2. cDNAs were PCR amplified with either bICP0 (left panels) or bICP22 (right panels) primer. The 1 lane in N(6) and T(12–18) bICP22 panels
is the same positive control, as bICP22-amplified products from N(6) and T(12–18)-primed cDNAs were run in the same gel. PCRs from both N(6) and T(12–18) cDNAs
were run at the same time with the same PCR mix. (Top panels) Amplification from bICP0 or bICP22 RNA in random-primed cDNA [N(6)]. (Bottom panels)
Amplification from bICP0 or bICP22 RNA in oligo(dT)-primed cDNA [T(12–18)].
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All primers were selected to anneal at the same temperature
and when possible to amplify the 39 end of the respective
transcript. Therefore, the primers used in this study should not
detect transcripts which prematurely terminate. Computer
analysis did not predict complex secondary structures between
any of the primer sets and the 39 end of the respective tran-
script. There are no adenine-rich sequences in any of the
primer sets and the 39 end of the respective transcripts, making
it unlikely that the oligo(dT) primer would anneal nonspecifi-
cally. The strategy for designing primers was successful, be-
cause the respective primer pairs had similar efficiency (Fig. 2),
and they detected IE RNA expression prior to E or L RNAs in
nonneural cells (Fig. 3 to 6).
It is likely that viral proteins are primarily translated from
FIG. 5. Detection of E transcripts during an in vitro lytic infection. Infections, RNA preparation, and controls were the same as described in the legend to Fig. 2.
cDNAs were PCR amplified with either RR (left panels) or TK (right panels) primer. (Top panels) Amplification from RR or TK RNA in random-primed cDNA [N(6)].
The RR panel is a composite figure. (Bottom panels) Amplification from RR or TK RNA in oligo(dT)-primed cDNA [T(12–18)].
FIG. 6. Detection of L transcripts during an in vitro lytic infection. Infections, RNA preparation, and controls were the same as described in the legend to Fig. 2.
cDNAs were PCR amplified with either gC (left panels) or aTIF (right panels) primer. (Top panels) Amplification from gC or aTIF RNA in random-primed cDNA
[N(6)]. The gC panel is a composite figure. (Bottom panels) Amplification from gC or aTIF RNA in oligo(dT)-primed cDNA [T(12–18)].
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FL&P transcripts, and thus their expression has more biolog-
ical relevance. Since cDNA synthesis which is primed by
poly(dT) primers leads primarily to amplification of poly(A)1
RNA, we believe this procedure reflects FL&P RNA. In con-
trast to a productive infection in rabbit kidney cells, bICP22
(IE and L) and RR (E) transcripts (FL&P) were detected
before IE transcripts (FL&P), during the acute phase of a TG
infection (Fig. 7 to 10). It is not clear whether RR proteins
were expressed prior to IE proteins, because RR protein ex-
pression is regulated by posttranscriptional mechanisms (49,
50). Although RR primers detected two transcripts, bICP4 and
bICP22 primers also detected two transcripts because these IE
genes are located in the genomic repeats (44, 45) (Fig. 1).
Furthermore, the IE/1 primers detected three transcripts,
(bICP4, bICP0, and bcirc), and one of them (bICP4) is diploid
(Fig. 1). Therefore, the ability of the RR primers to detect the
transcripts of the large and small subunits of RR was not the
sole reason for their early detection. It is also possible that
FL&P IE RNAs were expressed before E transcripts, but their
levels were too low to be detected by RT-PCR.
BHV-1 IE promoters are activated by aTIF (28, 29), sug-
gesting that if aTIF protein is transported into the nucleus of
a neuron with the rest of the tegument it does not stimulate IE
promoter activity. There is also evidence that HSV-1 IE pro-
moter activity is repressed by neuron-specific transcription fac-
tors (21, 25, 26). IE RNA expression may also be repressed
because of premature termination or improper splicing/pro-
cessing. This hypothesis is based on three findings: (i) IE RNA
FIG. 7. Detection of IE transcripts during an in vivo infection of TG. cDNAs from TG of BHV-1-infected or control calves and a positive control were PCR
amplified, blotted to a Nylon membrane, and hybridized with the respective probes. RNA was extracted from TG of calves euthanized at 1, 2, 4, 7, or 15 days pi as
indicated, DNase I-treated, reverse transcribed with the indicated primer, and PCR amplified with either bICP4 (left panels) or IE/1 (right panels) primer. As a positive
control, we used BHV-1 DNA (1). As negative controls we used RNA from mock-infected animals (MI) and amplifications in reaction tubes to which no template
was added (not shown). In this and all subsequent figures, the order of the samples from the calves, from left to right, is: 21, 41 (MI); 24, 50 (1 dpi); 73, 100 (2 dpi);
89, 90 (4 dpi), 25, 93 (7 dpi), and 200 (15 dpi). A molecular weight marker (phi X, HaeIII digested) was run in the lanes between the positive control at each side of
the gel and the first or last sample. In both N(6) panels, the positive control in the leftmost lane was a 1/10 dilution of the positive control in the rightmost lane. (Top
panels) Amplification from bICP4 or IETU1/E1 RNA in random-primed cDNA [N(6)].
FIG. 8. Detection of dual-kinetics transcripts during an in vivo infection of TG. Infection of calves, RNA preparation, and controls were the same as described in
the legend to Fig. 6. cDNAs were PCR amplified with either bICP0 (left panels) or bICP22 (right panels) primer. A molecular weight marker (phi X, HaeIII digested)
was run in the lanes between the positive control at each side of the gel and the first or last sample. (Top panels) Amplification from bICP0 or bICP22 RNA in
random-primed cDNA [N(6)]. (Bottom panels) Amplification from bICP0 or bICP22 RNA in oligo(dT)-primed cDNA [T(12–18)].
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was detected in TG after E RNA (FL&P), (ii) random priming
of cDNA allowed detection of IE transcripts before poly(dT)
priming of cDNA, and (iii) random priming or poly(dT) prim-
ing of cDNA led to simultaneous detection of RR transcripts.
The delay in detecting (FL&P) IE RNA can be explained by at
least four different mechanisms: (i) polyadenylation does not
readily occur in infected TG, (ii) the 39 end of IE RNAs is
prone to degradation in neurons, (iii) transcription prema-
turely terminates, and/or (iv) splicing of IE RNAs does not
readily occur in neurons. Conversely, it is possible that FL&P
IE transcripts were only transiently expressed in a small subset
of neurons and thus not detected. The fact that IE genes are
present in regions which are high in GC content may make it
more difficult to detect FL&P IE transcripts. To rule out the
possibility that FL&P IE RNA is not the first RNA expressed
in a few infected neurons or that our approach was not sensi-
tive enough to measure the initial expression of IE RNA, it will
be necessary to develop procedures which can accurately mea-
sure viral gene expression from single neurons or by in situ
techniques.
The finding that polyadenylated bICP22 and RR transcripts
were detected before IE RNA suggested their respective pro-
moters were activated by cellular factors, the transcripts were
stable in infected neurons, and/or the transcripts were more
efficiently polyadenylated. Since bICP0 represses the bICP22
promoter (54), this may explain in part the relative abundance
FIG. 9. Detection of E transcripts during an in vivo infection of TG. Infection of calves, RNA preparation and controls were the same as described in the legend
to Fig. 6. cDNAs were PCR amplified with either RR (left panels) or TK (right panels) primer. A molecular weight marker (phi X, HaeIII digested) was run in the
lanes between the positive control at each side of the gel and the first or last sample. (Top panels) Amplification from RR or TK RNA in random-primed cDNA [N(6)].
(Bottom panels) Amplification from RR or TK RNA in oligo(dT)-primed cDNA [T(12–18)].
FIG. 10. Detection of L transcripts during an in vivo infection of TG. Infection of calves, RNA preparation, and controls were the same as described in the legend
to Fig. 6. cDNAs were PCR amplified with either gC (left panels) or aTIF (right panels) primer. A molecular weight marker (phi X 174, HaeIII digested) was run in
the lanes between the positive control at each side of the gel and the first or last sample. (Top panels) Amplification from gC or aTIF RNA in random-primed cDNA
[N(6)]. In the gC panel, variability in the intensity of the signal among different calves is representative. Both positive control lanes were run at the left of the gel. The
double band observed in all calves is usually seen in PCRs performed with these primers. In the aTIF panel, the bands of higher molecular weight are occasionally
observed in amplifications of N(6)-primed cDNAs. They may be produced by nonspecific annealing of the primers. (Bottom panels) Amplification from gC or aTIF
RNA in oligo(dT)-primed cDNA [T(12–18)].
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of bICP22. Cellular factors associated with proliferation (c-jun
or c-myc) activate the HSV-2 large subunit of the RR pro-
moter (14, 56). A transcription factor that regulates cell cycle
progression, E2F, activates the HSV-1 TK promoter through
GC-rich DNA sequences which contain consensus Sp1 binding
sites (48). Cellular factors in certain cell types, including a
mouse neuroblastoma cell line, can replace ICP0 for activation
of E promoters and support an HSV-1 infection (5, 33, 57).
These factors are active when cells are released from growth
arrest, suggesting a factor involved with the cell cycle is re-
sponsible for this activity. Interestingly, our recent results de-
termined that cyclin A, a protein required for S phase, was
induced in neurons of rabbit TG during the acute phase of a
BHV-1 infection and reactivation (43). It is also possible that
novel BHV-1 gene products may be expressed in neurons and
stimulate expression of certain viral genes in the absence of IE
gene expression. This hypothesis is supported by the finding
that in the absence of ICP4, a novel viral transcript, L/ST or
ORF P, is expressed by HSV-1 (4, 24, 58).
ICP22 is a conserved gene which is present in HSV-1,
HSV-2, pseudorabies virus, VZV, equine herpesvirus 1 and 4,
and Marek’s disease virus (17, 45, 59). Since HSV-1 ICP22
induces an infection-specific phosphorylation of the carboxy-
terminal domain of RNA PolII (36) and is essential for viral
growth in certain cell lines (47), it is likely that bICP22 plays a
regulatory role in a BHV-1 infection. Its prolonged expression
during an acute infection in TG also suggested that it plays a
role in establishing a latent BHV-1 infection.
Two independent studies with other alphaherpesviruses have
concluded that tissue-specific viral gene expression occurs. When
human neurons or Schwann cells are infected with VZV, lim-
ited E gene expression was detected before IE gene expression
(2). As expected, VZV IE genes were detected before E genes
in human fibroblasts or astrocytes, supporting the hypothesis
that viral gene expression is regulated by cell-specific factors.
Inhibitors of viral TK, viral DNA polymerase, or TK deletion
mutants reduced HSV-1 IE gene expression in TG neurons
(22, 23). Furthermore, extensive IE expression only occurs
after viral DNA replication in neurons, suggesting that an
inhibitor of IE expression is titrated out after an increase in
genome copies. Our studies support these conclusions and
provide evidence that cell-type-specific expression of BHV-1
genes occurred during an in vivo infection of bovine TG.
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